300 related articles for article (PubMed ID: 22490869)
21. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter.
Zhu XS; Linhoff MW; Li G; Chin KC; Maity SN; Ting JP
Mol Cell Biol; 2000 Aug; 20(16):6051-61. PubMed ID: 10913187
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.
Brickey WJ; Wright KL; Zhu XS; Ting JP
J Immunol; 1999 Dec; 163(12):6622-30. PubMed ID: 10586057
[TBL] [Abstract][Full Text] [Related]
23. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
Hasegawa SL; Boss JM
Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the RFX complex and the RFX5(L66A) mutant: implications for the regulation of MHC class II gene expression.
Garvie CW; Stagno JR; Reid S; Singh A; Harrington E; Boss JM
Biochemistry; 2007 Feb; 46(6):1597-611. PubMed ID: 17279624
[TBL] [Abstract][Full Text] [Related]
25. Interaction of EF-C/RFX-1 with the inverted repeat of viral enhancer regions is required for transactivation.
David E; Garcia AD; Hearing P
J Biol Chem; 1995 Apr; 270(14):8353-60. PubMed ID: 7713944
[TBL] [Abstract][Full Text] [Related]
26. The S box of major histocompatibility complex class II promoters is a key determinant for recruitment of the transcriptional co-activator CIITA.
Muhlethaler-Mottet A; Krawczyk M; Masternak K; Spilianakis C; Kretsovali A; Papamatheakis J; Reith W
J Biol Chem; 2004 Sep; 279(39):40529-35. PubMed ID: 15271997
[TBL] [Abstract][Full Text] [Related]
27. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.
Gobin SJ; Peijnenburg A; van Eggermond M; van Zutphen M; van den Berg R; van den Elsen PJ
Immunity; 1998 Oct; 9(4):531-41. PubMed ID: 9806639
[TBL] [Abstract][Full Text] [Related]
28. Expression regulation and function of NLRC5.
Yao Y; Qian Y
Protein Cell; 2013 Mar; 4(3):168-75. PubMed ID: 23483478
[TBL] [Abstract][Full Text] [Related]
29. Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.
Vijayan S; Sidiq T; Yousuf S; van den Elsen PJ; Kobayashi KS
Immunogenetics; 2019 Mar; 71(3):273-282. PubMed ID: 30706093
[TBL] [Abstract][Full Text] [Related]
30. A hierarchy of nuclear localization signals governs the import of the regulatory factor X complex subunits and MHC class II expression.
Nagarajan UM; Long AB; Harreman MT; Corbett AH; Boss JM
J Immunol; 2004 Jul; 173(1):410-9. PubMed ID: 15210800
[TBL] [Abstract][Full Text] [Related]
31. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters.
Reith W; Kobr M; Emery P; Durand B; Siegrist CA; Mach B
J Biol Chem; 1994 Aug; 269(31):20020-5. PubMed ID: 8051086
[TBL] [Abstract][Full Text] [Related]
32. NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
Yoshihama S; Roszik J; Downs I; Meissner TB; Vijayan S; Chapuy B; Sidiq T; Shipp MA; Lizee GA; Kobayashi KS
Proc Natl Acad Sci U S A; 2016 May; 113(21):5999-6004. PubMed ID: 27162338
[TBL] [Abstract][Full Text] [Related]
33. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
[TBL] [Abstract][Full Text] [Related]
34. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
Durand B; Sperisen P; Emery P; Barras E; Zufferey M; Mach B; Reith W
EMBO J; 1997 Mar; 16(5):1045-55. PubMed ID: 9118943
[TBL] [Abstract][Full Text] [Related]
35. Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer.
Westerheide SD; Boss JM
Nucleic Acids Res; 1999 Apr; 27(7):1635-41. PubMed ID: 10075994
[TBL] [Abstract][Full Text] [Related]
36. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.
Nekrep N; Jabrane-Ferrat N; Peterlin BM
Mol Cell Biol; 2000 Jun; 20(12):4455-61. PubMed ID: 10825209
[TBL] [Abstract][Full Text] [Related]
38. Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter.
Caretti G; Cocchiarella F; Sidoli C; Villard J; Peretti M; Reith W; Mantovani R
J Mol Biol; 2000 Sep; 302(3):539-52. PubMed ID: 10986117
[TBL] [Abstract][Full Text] [Related]
39. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.
Durand B; Kobr M; Reith W; Mach B
Mol Cell Biol; 1994 Oct; 14(10):6839-47. PubMed ID: 7935401
[TBL] [Abstract][Full Text] [Related]
40. CITA/NLRC5: A critical transcriptional regulator of MHC class I gene expression.
Downs I; Vijayan S; Sidiq T; Kobayashi KS
Biofactors; 2016 Jul; 42(4):349-57. PubMed ID: 27087581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
